EN
HI
Summary
As of 19 Sep, 2026, Jubilant Pharmova stock price is ₹1065.4. During the trading session, the stock has moved between an intraday low of ₹1012.10 and an intraday high of ₹1086.00. Over the last 52 weeks, Jubilant Pharmova has traded between ₹786.05 and ₹1184.80.
The stock has recorded a trading volume of 3,08,313 shares,. Its Average Traded Price (ATP) is ₹1047.87, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 842 @ ₹1065.40.
Jubilant Pharmova has an upper circuit limit of ₹1278.45 and a lower circuit limit of ₹852.35. The total value traded stands at ₹32.31 CR, and the delivery percentage for the day is 44.31%.
The stock is currently traded with a market lot size of 1. Jubilant Pharmova also offers a dividend yield of 0.47%.
Jubilant Pharmova Share Price Chart
Jubilant Pharmova Share Key Metrics
Volume
3.08 L
Market Cap
16969.81 CR
LTQ@LTP
842@1065.40
ATP
1047.87
Var Margin
16.84 %
Circuit Range
852.35-1278.45
Delivery %
44.31 %
Value
32.31 CR
ASM/GSM
No
Market Lot
1
Jubilant Pharmova Fundamentals
P/E Ratio
48.28
P/B Ratio
2.38
Div. Yield
0.47
Sector P/E
42.35
Sector P/B
3.6
Sec. Div. Yield
0.51
Jubilant Pharmova Resistance and Support
Pivot 1011.68
Resistance
First Resistance
1026.31
Second Resistance
1040.53
Third Resistance
1055.16
Support
First Support
997.46
Second Support
982.83
Third Support
968.61
Jubilant Pharmova Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 1012.1 | 1065.4 | 5.27% | 1086 | 1012.1 |
| Thu Sep 17 2026 | 1002 | 1012.09 | 0.96% | 1025.9 | 997.04 |
| Wed Sep 16 2026 | 1010 | 1002.5 | -0.93% | 1010 | 977.5 |
Jubilant Pharmova Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-08-07 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-16 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
Jubilant Pharmova News
Jubilant Pharmova Ltd - 530019 - Update On USFDA Spokane
Jubilant Pharmova announced its Spokane, WA CMO facility received a 'Voluntary Action Indicated' (VAI) classification from the USFDA following an inspection from June 8-17, 2026. This classification indicates no immediate regulatory action is required.
Sep 11 2026 19:42:01
Jubilant Pharmova Ltd - 530019 - Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST
Jubilant Pharmova has received a show cause notice from the Assistant Commissioner of Commercial Taxes, Mysore, demanding Rs. 87.31 Cr in GST, interest, and penalty for FY2022-23. The company plans to file a detailed reply, asserting the notice is factually and legally incorrect, and expects no financial impact.
Sep 01 2026 12:42:45
Read More
Jubilant Pharmova Management
| Name | Position |
|---|---|
| Naresh Kapoor | Company Secretary & Compliance Officer |
| Shyam S Bhartia | Chairman |
Jubilant Pharmova Similar Stocks
Poly Medicure Ltd.
1726.00
13.30 (0.78%)
Cohance Lifesciences Ltd.
438.00
-1.95 (0.44%)
Alembic Pharmaceuticals Ltd.
845.75
19.75 (2.39%)
Dr. Agarwal's Health Care Ltd.
500.45
0.30 (0.06%)
Concord Biotech Ltd.
1494.40
33.30 (2.28%)
Molbio Diagnostics Ltd.
1288.30
3.00 (0.23%)
Vijaya Diagnostic Centre Ltd.
1558.90
52.80 (3.51%)
Rainbow Children's Medicare Ltd.
1454.70
-18.70 (1.27%)
Natco Pharma Ltd.
813.40
-4.85 (0.59%)
Jubilant Pharmova FAQs
The Buying Price of Jubilant Pharmova share is 1065.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jubilant Pharmova stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jubilant Pharmova, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jubilant Pharmova shares is 48.28. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jubilant Pharmova shares is 2.38. Useful to assess the stock's value relative to its book value.
To assess Jubilant Pharmova’s valuation compare Sector P/E, P/B which are 42.35 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jubilant Pharmova is 16969.81 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jubilant Pharmova share price is 1184.80 & 786.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jubilant Pharmova belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JUBLPHARMA
Or Download Choice FinX App
Invest in JUBLPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade